Regulation of neuroprotective action of vasoactive intestinal peptide in the murine developing brain by protein kinase C and mitogen-activated protein kinase cascades: In vivo and in vitro studies

Journal of Neurochemistry

Volumn 70, Issue 6, 1998, Pages 2574-2584

  Gressens, Pierre ^a   Marret, Stéphane ^c   Martin, Jean Luc ^d   Laquerrière, Annie ^c   Lombet, Alain ^b   Evrard, Philippe ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c HÔPITAL CHARLES NICOLLE   (France)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Excitotoxicity; Ibotenate; MEK 1; Mitogen activated protein kinase; Protein kinase C; Vasoactive intestinal peptide

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BISINDOLYLMALEIMIDE; CALMIDAZOLIUM; DANTROLENE; MITOGEN ACTIVATED PROTEIN KINASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEIN KINASE C; VASOACTIVE INTESTINAL POLYPEPTIDE; WORTMANNIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME REGULATION; IMMUNOHISTOCHEMISTRY; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SURVIVAL TIME;

ANIMALIA; MURINAE;

EID: 0031800131     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70062574.x     Document Type: Article

References (34)

1. Adamaou J. E., Aiyar N., Van Horn S., and Elshourbagy N. A. (1995) Cloning and functional characterization of the human vasoactive intestinal peptide (VIP)-2 receptor. Biochem. Biophys. Res. Commun. 209, 385-392.
2. Arimura A., Somogyvari-Vigh A., Well C., Fiore R. C., Tatsuno I., Bay V., and Brenneman D. E. (1994) PACAP functions as a neurotrophic factor. Ann. NY Acad. Sci. 739, 228-243.
3. Brenneman D. E. and Eiden L. D. (1986) Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc. Natl. Acad. Sci. USA 83, 1159-1162.
4. Brenneman D. E. and Gozes I. (1996) A fentomolar-actmg neuroprotective peptide. J. Clin. Invest. 97, 2296-2307.
5. Brenneman D. E., Eiden L. E., and Siegel R. E. (1985) Neurotrophic action of VIP on spinal cord cultures. Peptides 6 (Suppl.), 35-39.
6. Brenneman D. E., Nicol T., Warren D., and Bowers L. M. (1990) Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen. J. Neurosci. Res. 25, 386-394.
7. Brenneman D. E., Hill J. M., Glazner G. W., Gozes I., and Phillips T. M. (1995) Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survival. Int. J. Dev. Neurosci. 13, 187-200.
8. Cardinaux J. R., Magistretti P. J., and Martin J. L. (1997) Brain-derived neurotrophic factor stimulates phosphorylation of stathmin in cortical neurons. Mol. Brain Res. 51, 220-228.
9. Fatatis A., Holtzclaw L. A., Avidor R., Brenneman D. E., and Russel J. T. (1994) Vasoactive intestinal peptide increases intracellular calcium in astroglia: synergism with alpha-adrenergic receptors. Proc. Natl. Acad. Sci. USA 91, 2036-2040.
10. Festoff B. E., Nelson P. G., and Brenneman D. E. (1996) Prevention of activity-dependent neuronal death: vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting, neurotrophic serpin, protease nexin. J. Neurobiol. 30, 255-266.
11. Gozes I., McCune S. K., Jacobson L., Warren D., Moody T. W., Fridkin M., and Brenneman D. E. (1991) An antagonist to vasoactive intestinal peptide: effects on cellular functions in the central nervous system. J. Pharmacol. Exp. Ther. 257, 959-966.
12. Gressens P., Hill J. M., Gozes I., Fridkin M., and Brenneman D. E. (1993) Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature 362, 155-158.
13. Gressens P., Hill J. M., Paindaveine B., Gozes I., Fridkin M., and Brenneman D. E. (1994) Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse. J. Clin. Invest. 94, 2020-2027.
14. Gressens P., Marret S., and Evrard P. (1996) Developmental spectrum of the excitotoxic cascade induced by ibotenate: a model of hypoxic insults in fetuses and neonates. Neuropathol. Appl. Neurol. 22, 498-502.
15. Gressens P., Marret S., Hill J. M., Brenneman D. E., Gozes I., Fridkin M., and Evrard P. (1997) Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. J. Clin. Invest. 100, 390-397.
16. Ishiara T., Shigemoto R., Mori K., Takahashi K., and Nagata S. (1992) Functional expression and tissue distribution of a novel receptor for vasoactive intestinal peptide. Neuron 8, 811-819.
17. 2 receptor: molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett. 334, 3-8.
18. Magistretti P. J. and Schorderet M. (1984) VIP and noradrenaline act synergistically to increase cyclic AMP in cerebral cortex. Nature 308, 280-282.
19. Marret S., Delpech B., Delpech A., Asou H., Girard N., Courel M.-N., Chauzy C., Maingonnat C., and Fessard C. (1994) Expression and effects of hyaluronan and of the hyaluronan-binding protein hyaluronectin in newborn rat brain glial cell cultures. J. Neurochem. 62, 1285-1295.
20. Marret S., Gressens P., Gadisseux J. F., and Evrard P. (1995a) Prevention by magnesium of excitotoxic neuronal death in the developing brain: an animal model for clinical intervention. Dev. Med. Child. Neurol. 37, 473-484.
21. Marret S., Mukendi R., Gadisseux J. F., Gressens P., and Evrard P. (1995b) Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J. Neuropathol. Exp. Neurol. 54, 358-370.
22. Marret S., Gressens P., and Evrard P. (1996) Neuronal migration disorders induced by ibotenate in the neocortex. Proc. Natl. Acad. Sci. USA 93, 15463-15468.
23. Martin J.-L., Feinstein D. L., Yu N., Sorg O., Rossier C., and Magistretti P. J. (1992) VIP receptor subtypes in mouse cerebral cortex: evidence for a differential localization in astrocytes, microvessels and synaptosomal membranes. Brain Res. 587, 1-12.
24. Martin J.-L., Gasser D., and Magistretti P. J. (1995) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide potentiate c-fos expression induced by glutamate in cultured cortical neurons. J. Neurochem. 65, 1-9.
25. Miettinen S., Roivainen R., Keinänen R., Hökfelt T., and Koistinaho J. (1996) Specific induction of protein kinase C delta subspecies after transient middle cerebral artery occlusion in the rat brain: inhibition by MK-801. J. Neurosci. 16, 6236-6245.
26. Miyata A., Jiang L., Dahl R. D., Kitada C., Kubo K., Fujino M., Minamino M., and Arimura A. (1990) Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PA-CAP38). Biochem. Biophys. Res. Commun. 170, 643-648.
27. Nelson K. B. and Ellenberg J. H. (1986) Antecedents of cerebral palsy. Multivariate analysis of risk. N. Engl. J. Med. 315, 81-86.
28. Olah Z., Lehel C., Anderson W. B., Brenneman D. E., and Agoston D. V. (1994) Subnanomolar concentration of VIP induces the nuclear translocation of protein kinase C in neonatal rat cortical astrocytes. J. Neurosci. Res. 39, 355-363.
29. Sano M., Kohno M., and Iwanaga M. (1995) The activation and nuclear translocation of extracellular signal-regulated kinases (RRK-1 and -2) appear not to be required for elongation of neuntes in PC12D cells. Brain Res. 688, 213-218.
30. Spengler D., Waeber C., Pantaloni C., Hoelboer F., Bockaert J., Seeburg P. H., and Journot L. (1993) Differential signal transduction by five splice variants of the PACAP receptor. Nature 365, 170-175.
31. Sreedharan S. P., Patel D. R., Huang J. X., and Goetzl E. J. (1993) Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor. Biochem. Biophys. Res. Commun. 193, 546-553.
32. Villalba M., Bockaert J., and Journot L. (1997) Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J. Neurosci. 17, 83-90.
33. Zauli G., Visani G., Bassini A., Caramelli E., Ottaviani E., Bertolaso L., Bertagnolo V., Borgatti P., and Capitani S. (1996) Nuclear translocation of protein kinase C-alpha and -zeta isoforms in HL-60 cells induced to differentiate along the granulocytic lineage by all-trans retinoic acid. Br. J. Haematol. 93, 542-550.
34. Zheng C. F. and Guan K. L. (1994) Cytoplasmic localization of the mitogen-activated protein kinase activator MEK. J. Biol. Chem. 269, 19947-19952.